In basic terms, Section 280E denies a marijuana business the ability to deduct its business expenses in computing its federal income tax liability.

"Cannabis mergers and acquisitions are making a comeback after a turbulent few years for the industry. Over the past several months, multibillion-dollar deals like Tilray's merger with Aphria and Trulieve's

Laura Stutz (Of Counsel-Madison, NJ) is featured in the November edition of Today's General Counsel Magazine with her article,

Drug Enforcement Administration (DEA) Administrative Law Judge (ALJ) John Mulrooney has cancelled the long-awaited cannabis re-scheduling hearing set for next week.

According to a report issued last week, tens of thousands of cannabis dispensary customers' personal data has been exposed following a data breach of a sales system that at least three

Employers in New Jersey must comply with a number of state laws and regulations that often impose different or more stringent requirements on employers than those imposed by federal law.

On January 11, 2023, the Department of Health and Human Services extended the COVID-19 public health emergency through at least April 11, 2023.

Wiley attorneys Keith Matthews and Jessica Vaughn, Ph.D., engage in an in-depth discussion of the recently enacted Medical Marijuana Cannabidiol Research Expansion Act...

The speakers will also discuss some of the more recent and significant trade secrets cases involving the cannabis industry to illustrate key takeaways.

Historic federal action would recognize medical benefits of cannabis and make Section 280E inapplicable to licensed cannabis operators.

Multiple news sources reported today that the DEA will be recommending rescheduling cannabis to a Schedule III drug.

This order directs the Attorney General to complete the rulemaking process to reschedule marijuana to Schedule III of the Controlled Substances Act.

A bill co-sponsored by California AG Rob Bonta, which aims to assist with the implementation of a ban on the sale of flavored tobacco in the state, was signed into law and will go into effect on January 1, 2025.

A replay of Potential Cannabis Rescheduling and Its Implications in the Financial Sector is now available for viewing.

Howard Sklamberg, Life Sciences & Healthcare Regulatory partner and former FDA Deputy Commissioner, was recently a guest on NPR's podcast 1A for its episode...

With the popularity of recreational and medical marijuana how is a company to enforce a drug policy? Just finding employees that don't use marijuana is a struggle but ignoring the possible risks and harm drug use...

The US Hemp Roundtable has done a fantastic job of summarizing pending legislation that could dramatically impact the sale of hemp products in Alabama...

A webinar replay of Mainstreaming Cannabis: Internal Revenue Code 280E and Tax Efficiency is now available for viewing.

A replay of Mainstreaming Cannabis: Legal Challenges and Considerations for Social Consumption Lounges is now available for viewing.

Cannabis practice co-chair Jesse Alderman spoke with the Boston Globe surrounding the firing of Massachusetts Cannabis Control Commission leader Shannon O'Brien, leaving multiple questions in its wake.